Security key
87164F105
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX)
CUSIP: 87164F105
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 86,328,130
- Total 13F shares
- 88,967,889
- Share change
- +1,259,515
- Total reported value
- $1,713,503,490
- Put/Call ratio
- 88%
- Price per share
- $19.25
- Number of holders
- 208
- Value change
- +$22,962,287
- Number of buys
- 119
- Number of sells
- 81
Report period
Q3 2024
Institutions
208
Top holders
10
SNDX full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Syndax Pharmaceuticals Inc SEC filings
Syndax Pharmaceuticals Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87164F105
Recent filing periods:
Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
9.2%
|
7,906,765
|
$162,325,885 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
8.5%
|
7,339,004
|
$150,669,751 | — | 30 Jun 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
6.6%
|
5,722,057
|
$117,473,830 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.6%
|
4,797,089
|
$98,484,237 | — | 30 Jun 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4.5%
|
3,888,437
|
$79,829,612 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.2%
|
3,622,335
|
$74,366,538 | — | 30 Jun 2024 | |
| Eversept Partners, LP |
13F
|
Company |
4.2%
|
3,613,631
|
$74,187,844 | — | 30 Jun 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
3.9%
|
3,335,000
|
$68,467,550 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
3.2%
|
2,782,853
|
$57,131,969 | — | 30 Jun 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
2.5%
|
2,153,669
|
$44,214,825 | — | 30 Jun 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2.2%
|
1,925,300
|
$39,526,409 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
1,910,623
|
$39,233,197 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
2.1%
|
1,830,427
|
$37,578,665 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.8%
|
1,555,234
|
$31,928,946 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.8%
|
1,545,528
|
$31,729,690 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.7%
|
1,444,012
|
$29,645,566 | — | 30 Jun 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
1.6%
|
1,412,176
|
$28,991,973 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.2%
|
1,065,508
|
$21,874,879 | — | 30 Jun 2024 | |
| Aisling Capital Management LP |
13F
|
Company |
1.2%
|
1,025,000
|
$21,043,250 | — | 30 Jun 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
1.1%
|
970,106
|
$19,915,347 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.1%
|
930,947
|
$19,112,342 | — | 30 Jun 2024 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1%
|
894,993
|
$18,374,206 | — | 30 Jun 2024 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
1%
|
875,000
|
$17,963,750 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1%
|
860,000
|
$17,655,800 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.99%
|
852,206
|
$17,495,788 | — | 30 Jun 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.96%
|
826,500
|
$16,968,045 | — | 30 Jun 2024 | |
| Commodore Capital LP |
13F
|
Company |
0.96%
|
825,000
|
$16,937,250 | — | 30 Jun 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.95%
|
822,047
|
$16,876,625 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.88%
|
756,232
|
$15,525,442 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.81%
|
696,729
|
$14,303,846 | — | 30 Jun 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.76%
|
657,074
|
$13,489,729 | — | 30 Jun 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.76%
|
656,250
|
$13,472,813 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.76%
|
654,489
|
$13,436,659 | — | 30 Jun 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.74%
|
640,389
|
$13,147,186 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.73%
|
629,880
|
$12,931,437 | — | 30 Jun 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.72%
|
625,723
|
$12,846,000 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.72%
|
621,252
|
$12,754,304 | — | 30 Jun 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.7%
|
600,698
|
$12,332,330 | — | 30 Jun 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.69%
|
594,386
|
$12,202,745 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.64%
|
556,414
|
$11,423,179 | — | 30 Jun 2024 | |
| Prosight Management, LP |
13F
|
Company |
0.64%
|
551,544
|
$11,323,198 | — | 30 Jun 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.6%
|
521,080
|
$10,697,764 | — | 30 Jun 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.6%
|
518,885
|
$10,652,709 | — | 30 Jun 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.53%
|
453,232
|
$9,304,853 | — | 30 Jun 2024 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.5%
|
432,128
|
$8,872,000 | — | 30 Jun 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.5%
|
428,949
|
$8,806,323 | — | 30 Jun 2024 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.49%
|
419,654
|
$8,615,497 | — | 30 Jun 2024 | |
| Palo Alto Investors LP |
13F
|
Company |
0.47%
|
405,193
|
$8,318,612 | — | 30 Jun 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.45%
|
387,357
|
$7,952,439 | — | 30 Jun 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.43%
|
370,000
|
$7,596,100 | — | 30 Jun 2024 |
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q3 2024
As of 30 Sep 2024,
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) was held by
208 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
88,967,889 shares.
The largest 10 holders included
BlackRock, Inc., Kynam Capital Management, LP, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Eversept Partners, LP, Avoro Capital Advisors LLC, STATE STREET CORP, Point72 Asset Management, L.P., Avidity Partners Management LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
208
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
195
Q3 2024 holders
208
Holder diff
13
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.